| Assay ID | Title | Year | Journal | Article |
|---|
| AID1568279 | Antiproliferative activity against human ATN1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay | 2019 | European journal of medicinal chemistry, Sep-15, Volume: 178 | Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. |
| AID1568280 | Antiproliferative activity against human K562 cells assessed as reduction in cell viability at 10 ug/ml measured after 24 hrs by MTT assay relative to control | 2019 | European journal of medicinal chemistry, Sep-15, Volume: 178 | Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. |
| AID1568277 | Inhibition of NF-kappaB localization in nucleus of human L540 cells at 10 ug/ml measured after 5 to 24 hrs by DAPI staining immunofluorescence microscopy | 2019 | European journal of medicinal chemistry, Sep-15, Volume: 178 | Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. |
| AID1568284 | Inhibition of TNF alpha stimulated NF-kappaB in human FL cells transfected with kappaB luciferase at 5 to 10 ug/ml incubated for 4 hrs followed by TNF alpha stimulation measured after 3 hrs by dual luciferase reporter gene assay | 2019 | European journal of medicinal chemistry, Sep-15, Volume: 178 | Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |